JP Morgan Chase
LSTA icon

JP Morgan Chase’s Lisata Therapeutics LSTA Stock Holding History

JP Morgan Chase’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13
Closed -$31 – 7414
2025
Q1 		$31 Sell
13
-2
-13% -$5 ﹤0.01% 7063
2024
Q4 		$45 Hold
15
– – ﹤0.01% 7155
2024
Q3 		$45 Sell
15
-1
-6% -$3 ﹤0.01% 7132
2024
Q2 		$56 Hold
16
– – ﹤0.01% 7007
2024
Q1 		$50 Buy
16
+5
+45% +$15 ﹤0.01% 7038
2023
Q4 		$30 Buy
11
+3
+38% +$7 ﹤0.01% 7281
2023
Q3 		$17 Buy
+8
New +$22 ﹤0.01% 7206
2018
Q2 		– Sell
-1,251
Closed -$110K – 5616
2018
Q1 		$110K Buy
+1,251
New +$86.6K ﹤0.01% 4563
2014
Q2 		– Sell
-90
Closed -$95K – 3577
2014
Q1 		$95K Buy
+90
New +$97.6K ﹤0.01% 3487

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase's LSTA Position: Q2 2025 in Review

JP Morgan Chase sold out of Lisata Therapeutics (LSTA) in Q2 2025, closing a stake of 13 shares — an estimated $31 sold.

JP Morgan Chase first reported a position in LSTA in Q1 2014 and held it in 9 quarters. The position peaked at $110K in Q1 2018. 20 funds tracked by Wall St. Rank hold LSTA as of Q2 2025.

  • JP Morgan Chase reported no remaining Lisata Therapeutics position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 13 Lisata Therapeutics shares in Q2 2025, an estimated $31.
  • JP Morgan Chase first reported a position in Lisata Therapeutics in Q1 2014 and held it in 9 quarters.
  • JP Morgan Chase's Lisata Therapeutics position peaked at $110K in Q1 2018.
  • 20 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.